Ligand To Acquire Pharmacopeia | Chemical & Engineering News
Volume 86 Issue 39 | p. 18 | Concentrates
Issue Date: September 29, 2008

Ligand To Acquire Pharmacopeia

Department: Business

Ligand Pharmaceuticals will acquire Pharmacopeia, a small-molecule drug discovery company, in a deal that values Pharmacopeia at up to $70 million. Ligand CEO John L. Higgins calls the deal "a great marriage of biology and chemistry resources." Pharmacopeia has cut its workforce in half in recent months as it seeks to conserve cash and concentrate on later-stage products.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment